| Name: | Fulvestrant Impurity 12 |
| Catalogue No. | VE006804 |
| CAS No. | 2490287-82-4 |
| Molecular Formula | C29H43ClO3 |
| Molecular Weight | 475.1 |
| Status | In-stock |
| IUPAC Name | (7R,8R,9S,13S,14S,17S)-7-(9-chlorononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl |
| Description | Fulvestrant Impurity 12 (CAS No. 2490287-82-4) or (7R,8R,9S,13S,14S,17S)-7-(9-chlorononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate is an impurity of Fulvestrant.Fulvestrant is a drug treatment of hormone receptor (HR)-positive metastatic breast cancer in post-menopausal women with disease progression following anti-estrogen therapy. |
| References | “Sci-Hub | Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer | 10.1056/Nejmoa1201622.” Hkvisa.net, 2012, sci-hub.hkvisa.net/10.1056/nejmoa1201622. |
![7β-Acetyloxy-7α-[9-(dimethyl(tert-butylsilyloxy)nonyl]estr-4-en-3-one](/public/site/files/site_images/thumb_7beta-acetyloxy-7alpha-9-dimethyl-tert-butylsilyloxy-nonyl-estr-4-en-3-one17932.png)
![Fulvestrant 9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonanol](/public/site/files/site_images/thumb_fulvestrant-944555pentafluoropentylthiononanol35935.PNG)
![Fulvestrant 9-[[9-[(4,4,5,5,5-Pentafluoropentyl)sulfenyl]nonyl]sulfenyl]nonyl Bromide](/public/site/files/site_images/thumb_fulvestrant-9944555pentafluoropentylsulfenylnonylsulfenylnonyl-bromide21235.PNG)
